Lin Huang - Publications

Deciphering the mechanism of enhanced scintillation properties in In-doped β-Ga2O3 ultrafast scintillation crystal.

Journal: Optics express

Published: February 20, 2026

The bleeding risk of low-molecular-weight heparin bridging therapy in patients receiving preoperative oral antithrombotic drugs during spinal fusion surgery.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: December 12, 2025

Hollow nanofactory with dotted interior surface produces potent hydroxyl radical to combat drug-resistant large tumors.

Journal: Materials today. Bio

Published: November 11, 2025

Symptom experiences and coping strategies of liver cancer patients receiving targeted therapy combined with immunotherapy in China: A qualitative study.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: September 02, 2025

HMGB1 as an emerging key modulator of bone remodeling: a narrative review.

Journal: Stem cell research & therapy

Published: April 29, 2025

Dual Functions and Therapeutic Potential of FZD6 in Biliary Atresia.

Journal: Digestive diseases and sciences

Published: February 18, 2025

Identification and immune characteristics of N6-methyladenosine related ferroptosis-related genes in intervertebral disc degeneration.

Journal: Scientific reports

Published: February 16, 2025

Early differential diagnosis of cystic biliary atresia and choledochal cyst in the fetus: A multicenter retrospective study.

Journal: Journal of hepato-biliary-pancreatic sciences

Published: January 28, 2025

GPC3: a novel mutated gene in pleuropulmonary blastoma.

Journal: Discover oncology

Published: January 16, 2025

HMGB1-mediated macrophage regulation of NF-κB activation and MMP3 upregulation in nucleus pulposus cells: A critical mechanism in the vicious cycle of intervertebral disc degeneration.

Journal: Cellular signalling

Published: November 28, 2024

FKBP5 promotes osteogenic differentiation of mesenchymal stem cells through type-I interferon pathway Inhibition.

Journal: Cellular and molecular life sciences : CMLS

Published: October 09, 2024

LncRNA MRF targeting FSHR inhibits the osteogenic differentiation of BMSCs and bone defect repair through the regulation of the cAMP-PKA-CREB signaling pathway.

Journal: Stem cell research & therapy

Published: July 24, 2024